Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin effects on CSF AD biomarkers
NCT01142336Phase 4Completed
- Sponsor
- University of Washington
- Start
- Jun 2010
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Alzheimer's disease (AD) comparing Simvastatin with Placebo (2 arms). Primary endpoints: Change From Baseline in Aβ42 in Cerebrospinal Fluid at 1 year, Change From Baseline in CSF Total Tau at 1 year and 1 more. Started Jun 2010; status: completed.
02
Drugs
simvastatin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01142336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01142336.